☆ 4.6 Letter

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 174, Issue 2, Pages 323-325

Publisher

WILEY-BLACKWELL
DOI: 10.1111/bjh.13765

Keywords

multiple myeloma; alisertib; aurora kinase; bortezomib; relapse

Categories

Hematology

Funding

  1. NCI NIH HHS [P50 CA186781, P30 CA016058] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.